Diffusion-weighted magnetic resonance imaging (DW-MRI) as an imaging biomarker: reproducibility of measurements in liver and lung.

Diffusion-weighted magnetic resonance imaging (DW-MRI) as an imaging biomarker: reproducibility of measurements in liver and lung. - DW-MRI

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON39706

Enrollment

Registered

2012-12-10

Start date

2013-02-20

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastasis neoplasma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Volunteer study * Age 30-50 or 60-80 years * Able to remain supine for 30 minutes in the scanner * Written informed consent Patient study * Age 18 years or older * Colorectal liver metastases or lung metastases, or primary lung cancer (histological confirmation only in uncertain metastatic deposits) * Minimum of one lesion > 2cm in diameter in liver or lung respectively * Able to remain supine for 30 minutes in the scanner * Written informed consent

Exclusion criteria

Exclusion criteria: * Contraindications for MRI * Antitumor treatment targeted on the evaluable liver metastasis * Antitumor treatment targeted less than 1 week prior to scan in malignant lung lesions * Claustrophobia

Design outcomes

Primary

Measure	Time frame
Reproducibility of apparent diffusion coefficient (ADC) measured with DW-MRI.	—

Countries

Netherlands

Outcome results